Creo Medical Group (LON:CREO) Stock Passes Above Fifty Day Moving Average – Here’s Why

Creo Medical Group PLC (LON:CREO)’s share price crossed above its fifty day moving average during trading on Friday . The stock has a fifty day moving average of GBX 12.27 and traded as high as GBX 12.50. Creo Medical Group shares last traded at GBX 11.75, with a volume of 367,287 shares.

Analyst Upgrades and Downgrades

Separately, Shore Capital Group reaffirmed a “house stock” rating on shares of Creo Medical Group in a research note on Thursday, April 16th.

Creo Medical Group Price Performance

The company has a market cap of £48.46 million, a P/E ratio of -11.75 and a beta of 1.50. The company has a fifty day moving average price of GBX 12.27 and a two-hundred day moving average price of GBX 12.15. The company has a debt-to-equity ratio of 6.90, a quick ratio of 2.19 and a current ratio of 5.28.

Creo Medical Group Company Profile

Creo Medical is a medical device company focused on the development and commercialisation of minimally invasive electrosurgical devices, bringing advanced energy to endoscopy.

The Company’s vision is to improve patient outcomes through the development and commercialisation of a suite of electrosurgical medical devices, each enabled by CROMA, powered by Kamaptive. The Group has developed the CROMA powered by Kamaptive full-spectrum adaptive technology to optimise surgical capability and patient outcomes.